このエントリーをはてなブックマークに追加


ID 66884
フルテキストURL
fulltext.pdf 4.25 MB
著者
Taniguchi, Rikako Department of Medicinal Pharmacology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University
Moriya, Yuto Department of Medicinal Pharmacology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University
Dohmae, Naoshi Biomolecular Characterization Unit, Technology Platform Division, RIKEN Center for Sustainable Resource Science
Suzuki, Takehiro Biomolecular Characterization Unit, Technology Platform Division, RIKEN Center for Sustainable Resource Science
Nakahara, Kengo Department of Medicinal Pharmacology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University
Kubota, Sho Department of Medicinal Pharmacology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University
Takasugi, Nobumasa Department of Medicinal Pharmacology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University
Uehara, Takashi Department of Medicinal Pharmacology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University ORCID Kaken ID
抄録
Upregulation of nitric oxide (NO) production contributes to the pathogenesis of numerous diseases via S-nitro- sylation, a post-translational modification of proteins. This process occurs due to the oxidative reaction between NO and a cysteine thiol group; however, the extent of this reaction remains unknown. S-Nitrosylation of PRMT1, a major asymmetric arginine methyltransferase of histones and numerous RNA metabolic proteins, was induced by NO donor treatment. We found that nitrosative stress leads to S-nitrosylation of cysteine 119, located near the active site, and attenuates the enzymatic activity of PRMT1. Interestingly, RNA sequencing analysis revealed similarities in the changes in expression elicited by NO and PRMT1 inhibitors or knockdown. A comprehensive search for PRMT1 substrates using the proximity-dependent biotin identification method highlighted many known and new substrates, including RNA-metabolizing enzymes. To validate this result, we selected the RNA helicase DDX3 and demonstrated that arginine methylation of DDX3 is induced by PRMT1 and attenuated by NO treatment. Our results suggest the existence of a novel regulatory system associated with transcription and RNA metabolism via protein S-nitrosylation.
キーワード
Nitric oxide
S-Nitrosylation
Protein arginine methyltransferase 1 (PRMT1)
RNA metabolism
Dead-box helicase 3X-linxed (DDX3)
発行日
2024-03
出版物タイトル
Journal of Pharmacological Sciences
154巻
3号
出版者
Japanese Pharmacological Society
開始ページ
209
終了ページ
217
ISSN
1347-8613
NCID
AA11806667
資料タイプ
学術雑誌論文
言語
英語
OAI-PMH Set
岡山大学
著作権者
© 2024 The Authors.
論文のバージョン
publisher
PubMed ID
DOI
Web of Science KeyUT
関連URL
isVersionOf https://doi.org/10.1016/j.jphs.2023.12.012
ライセンス
http://creativecommons.org/licenses/by-nc-nd/4.0/
助成機関名
Ministry of Education, Culture, Sports, Science and Technology
Smoking Research Foundation
Japan Science and Technology Agency
助成番号
22K19380
JPMJSP2126